Andrew Blumenfeld, MD: Long-Term OnabotulimuntoxinA Use in the COMPEL Study

Andrew Blumenfeld, MD: Long-Term OnabotulimuntoxinA Use in the COMPEL Study

Botox for Migraine by Dr Andrew BlumenfeldПодробнее

Botox for Migraine by Dr Andrew Blumenfeld

A Historic Perspective on Preventive Therapy for MigraineПодробнее

A Historic Perspective on Preventive Therapy for Migraine

Combination treatment with CGRP mAbs and onabotulinumtoxinA for chronic migraine controlПодробнее

Combination treatment with CGRP mAbs and onabotulinumtoxinA for chronic migraine control

Dr. Herbst on Combination of Nivolumab and Ipilimumab in Patients With NSCLCПодробнее

Dr. Herbst on Combination of Nivolumab and Ipilimumab in Patients With NSCLC

Andrew Blumenfeld on Migraine Pathophysiology - part 5Подробнее

Andrew Blumenfeld on Migraine Pathophysiology - part 5

Andrew Blumenfeld on Migraine Pathophysiology - part 3Подробнее

Andrew Blumenfeld on Migraine Pathophysiology - part 3

Emirates Neurology Virtual Congress 4-6 February 2021 - Dr. Andew BlumenfeldПодробнее

Emirates Neurology Virtual Congress 4-6 February 2021 - Dr. Andew Blumenfeld

Focus On MigraineПодробнее

Focus On Migraine

MIS "Over the Top" ULBD for contralateral foraminal disc herniationПодробнее

MIS 'Over the Top' ULBD for contralateral foraminal disc herniation

Fred Cohen, MD: OnabotulinumtoxinA and CGRP Combination TreatmentПодробнее

Fred Cohen, MD: OnabotulinumtoxinA and CGRP Combination Treatment

Combination treatment for migraineПодробнее

Combination treatment for migraine

Andrew Blumenfeld on Migraine Pathophysiology - part 2Подробнее

Andrew Blumenfeld on Migraine Pathophysiology - part 2

OnabotulinumtoxinA in elderly patients with chronic migraine: real-world evidenceПодробнее

OnabotulinumtoxinA in elderly patients with chronic migraine: real-world evidence